In one study by Shihan et al. RASSF1A promoter hypermethylation was reported in 47% of colorectal tumors versus 13% of paired normal tissue specimens, with significant associations between methylation status and tumor stage, metastasis, and lymphatic invasion [22]. The gene discussed is RASSF1; the disease is colorectal neoplasm.